SS 27 - Heme 1: Glowing Results: Clinical Trials of Radiation in Lymphoma

Moderator(s)

• 

  Jillian Gunther, MD, PhD

  The University of Texas MD Anderson Cancer Center
  Houston, TX
• RP

  Rahul Parikh, MD, MBA

  Rutgers Cancer Institute of New Jersey
  New Brunswick, NJ

Presentations:

• 5:00 PM – 5:10 PM ET

  Long-Term Update of a Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma
  

  Presenter: Christina Huang, MD, MS – Duke University School of Medicine
• 5:10 PM – 5:20 PM ET

  Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia
  

  Presenter: Jeffrey Wong, MD, FASTRO – City of Hope National Medical Center
• 5:20 PM – 5:30 PM ET

  Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Sub-Study of Childrens Oncology Group AHOD 0431
  

  Presenter: Sarah Milgrom, MD – University of Colorado Denver
• 5:30 PM – 5:40 PM ET

  Initial Results of the Multicenter Phase II Trial of a Novel Hypofractionated Low-Dose Radiotherapy for Indolent Non-Hodgkin Lymphoma
  

  Presenter: Xinyue Wang, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
• 5:40 PM – 5:50 PM ET

  A Proof-of-Principle Study of Split-Course Bridging Radiotherapy (SC-BRT) prior to Commercial CAR T-Cell Therapies for Relapsed or Refractory B-Cell Lymphomas: Results from Phase 1a Pilot Cohort
  

  Presenter: Brandon Imber, MD, MS – Memorial Sloan Kettering Cancer Center
• 5:50 PM – 6:00 PM ET

  Discussant
  

  Discussant: Hans Theodor Eich, MD, PhD – University of Muenster